(Q38872426)

7 September 2017

title

Slug contributes to gemcitabine resistance through epithelial-mesenchymal transition in CD133(+) pancreatic cancer cells (English)

1 reference

7 September 2017

1 reference

Koichiro Tsukasa

1

1 reference

7 September 2017

Qiang Ding

2

1 reference

7 September 2017

Makoto Yoshimitsu

3

1 reference

7 September 2017

Yumi Miyazaki

4

1 reference

7 September 2017

Shyuichiro Matsubara

5

1 reference

7 September 2017

Sonshin Takao

6

1 reference

7 September 2017

publication date

22 May 2015

1 reference

7 September 2017

1 reference

7 September 2017

volume

28

1 reference

7 September 2017

issue

4

1 reference

7 September 2017

page(s)

167-174

1 reference

7 September 2017

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Pancreatic cancer stem cells: regulatory networks in the tumor microenvironment and targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Identification of pancreatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Epithelial-mesenchymal transitions in development and pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Epithelial-mesenchymal transitions in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Biomarkers for epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Zinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Snail and slug play distinct roles during breast carcinoma progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelial-mesenchymal transition in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Slug increases sensitivity to tubulin-binding agents via the downregulation of βIII and βIVa-tubulin in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Comprehensive patterns in microRNA regulation of transcription factors during tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Regulatory coordination of clustered microRNAs based on microRNA-transcription factor regulatory network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13577-015-0117-3

Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition

21 January 2018

1 reference

12 December 2020

Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.

1 reference

12 December 2020

Oncogene-induced basement membrane invasiveness in human mammary epithelial cells

1 reference

12 December 2020

Induction of an epithelial-mesenchymal transition by an in vivo adheron-like complex

1 reference

12 December 2020

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

12 December 2020

10.1007/S13577-015-0117-3

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1029773369

0 references

1 reference